8'-Epicleomiscosin ACAS# N/A |
2D Structure
- Cleomiscosin A
Catalog No.:BCN4320
CAS No.:76948-72-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | N/A | SDF | Download SDF |
PubChem ID | 11200016 | Appearance | Powder |
Formula | C20H18O8 | M.Wt | 386.36 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Synonyms | 8'-epi-cleomiscosin A | ||
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol | ||
Chemical Name | (2S,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one | ||
SMILES | COC1=C(C=CC(=C1)C2C(OC3=C4C(=CC(=C3O2)OC)C=CC(=O)O4)CO)O | ||
Standard InChIKey | OCBGWPJNUZMLCA-DOTOQJQBSA-N | ||
Standard InChI | InChI=1S/C20H18O8/c1-24-13-7-10(3-5-12(13)22)17-15(9-21)26-20-18-11(4-6-16(23)27-18)8-14(25-2)19(20)28-17/h3-8,15,17,21-22H,9H2,1-2H3/t15-,17+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 8'-Epicleomiscosin A shows strong inhibition (IC50=1.33 microM) against the enzyme tyrosinase, as compared to the standard tyrosinase inhibitors kojic acid (IC50=16.67 microM) and L-mimosine (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes. |
8'-Epicleomiscosin A Dilution Calculator
8'-Epicleomiscosin A Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5883 mL | 12.9413 mL | 25.8826 mL | 51.7652 mL | 64.7065 mL |
5 mM | 0.5177 mL | 2.5883 mL | 5.1765 mL | 10.353 mL | 12.9413 mL |
10 mM | 0.2588 mL | 1.2941 mL | 2.5883 mL | 5.1765 mL | 6.4706 mL |
50 mM | 0.0518 mL | 0.2588 mL | 0.5177 mL | 1.0353 mL | 1.2941 mL |
100 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.5177 mL | 0.6471 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Polygodial
Catalog No.:BCC7597
CAS No.:6754-20-7
- Dehydrotumulosic acid
Catalog No.:BCN3740
CAS No.:6754-16-1
- Helenalin
Catalog No.:BCN8073
CAS No.:6754-13-8
- Alpha-caryophyllene
Catalog No.:BCN3877
CAS No.:6753-98-6
- Thapsigargin
Catalog No.:BCC6952
CAS No.:67526-95-8
- 4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile
Catalog No.:BCC8710
CAS No.:675126-26-8
- Spathulenol
Catalog No.:BCN4227
CAS No.:6750-60-3
- Arnidiol
Catalog No.:BCN3810
CAS No.:6750-30-7
- Eupatolide
Catalog No.:BCN7345
CAS No.:6750-25-0
- Fuegin
Catalog No.:BCN5809
CAS No.:6750-10-3
- DIDS
Catalog No.:BCC7942
CAS No.:67483-13-0
- GBR 12935 dihydrochloride
Catalog No.:BCC5380
CAS No.:67469-81-2
- Nutlin-3b
Catalog No.:BCC1156
CAS No.:675576-97-3
- Nutlin-3a chiral
Catalog No.:BCC1812
CAS No.:675576-98-4
- PG 01037 dihydrochloride
Catalog No.:BCC7801
CAS No.:675599-62-9
- Lariciresinol dimethyl ether
Catalog No.:BCN4228
CAS No.:67560-68-3
- Maoyecrystal E
Catalog No.:BCN3283
CAS No.:675603-39-1
- Baicalein 7-O-beta-D-ethylglucuronide
Catalog No.:BCN7981
CAS No.:675624-38-1
- Diosbulbin G
Catalog No.:BCN4229
CAS No.:67567-15-1
- Hydrangenol 8-O-glucoside
Catalog No.:BCN4230
CAS No.:67600-94-6
- 5,7,2'-Trihydroxyflavanone
Catalog No.:BCC9241
CAS No.:120980-68-9
- Clerodermic acid methyl ester
Catalog No.:BCN4231
CAS No.:67650-47-9
- Methylenetanshinquinone
Catalog No.:BCN3156
CAS No.:67656-29-5
- 9-Hydroxycamptothecin
Catalog No.:BCC8276
CAS No.:67656-30-8
Tyrosinase inhibitors from Rhododendron collettianum and their structure-activity relationship (SAR) studies.
Chemical & Pharmaceutical Bulletin [2004, 52(12):1458-1461]
A new coumarinolignoid 8'-Epicleomiscosin A (1) together with the new glycoside 8-O-beta-D-glucopyranosyl-6-hydroxy-2-methyl-4H-1-benzopyrane-4-one (2) have been isolated from the aerial parts of Rhododendron collettianum and their structures determined on the basis of spectroscopic evidences. Tyrosinase inhibition study of these compounds and their structure-activity relationship (SAR) were also investigated. The compounds exhibited potent to mild inhibition activity against the enzyme. Especially, 8'-Epicleomiscosin A showed strong inhibition (IC50=1.33 microM) against the enzyme tyrosinase, as compared to the standard tyrosinase inhibitors kojic acid (IC50=16.67 microM) and L-mimosine (IC50=3.68 microM), indicating its potential used for the treatment of hyperpigmentation associated with the high production of melanocytes.